Faculty

Denise Boudreau

Affiliate Professor, Epidemiology
Affiliate Professor, Pharmacy

206-287-2067
boudreau.d@ghc.org

Education

PhD Pharmacoepidemiology, University of Washington, 2002
MS Pharmacy Administration, University of Rhode Island, 1996
BS Pharmacy, University of Rhode Island, 1992

Contact

206-287-2067
boudreau.d@ghc.org

Kaiser Permanente Washington Health Research Institute
1730 Minor Ave, Suite 1600
Seattle, WA 98101

Bio

Dr. Boudreau is a Senior Investigator at the Group Health Research Institute as well as an affiliate faculty member in both the Department of Epidemiology and Pharmacy at the University of Washington. She is involved in a wide array of pharmacoepidemiology and pharmacoeconomic research projects at Group Health and across the HMO Research Network (HMORN). She has extensive experience working with automated health plan data and bring expertise in the areas of observational study design/comparative effectiveness, managed care, drug safety, and economic evaluation. She has been the HMORN Steering Committee Representative on the FDA Mini Sentinel Initiative since 2009. Her main research interests include cancer pharmacoepidemiology, opioid safety, bone health, and cost of cancer.

Research Areas

Research Interests

Pharmacoepidemiology and pharmacoeconomics

Recent Publications (PubMed)

Safety of opioid prescribing among older cancer survivors.
(2021 Oct 11)
Cancer
Salz T, Mishra A, Gennarelli RL, Lipitz-Snyderman A, Moryl N, Tringale KR, Boudreau DM, Kriplani A, Jinna S, Korenstein D

Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems.
(2021 Jul 7)
Addict Sci Clin Pract 16(1): 46
Bagley SM, Chavez L, Braciszewski JM, Akolsile M, Boudreau DM, Lapham G, Campbell CI, Bart G, Yarborough BJH, Samet JH, Saxon AJ, Rossom RC, Binswanger IA, Murphy MT, Glass JE, Bradley KA, PROUD Collaborative.

STRategies to Improve Pain and Enjoy life (STRIPE): Protocol for a pragmatic randomized trial of pain coping skills training and opioid medication taper guidance for patients on long-term opioid therapy.
(2021 Jul 2)
Contemp Clin Trials 110(): 106499
Wartko PD, Boudreau DM, Turner JA, Cook AJ, Wellman RD, Fujii MM, Garcia RC, Moser KA, Sullivan MD

Prevalence of prescription opioid use during pregnancy in eight US health plans during 2001-2014.
(2021 Nov)
Pharmacoepidemiol Drug Saf 30(11): 1541-1550
Pocobelli G, Dublin S, Bobb JF, Albertson-Junkans L, Andrade S, Cheetham TC, Salgado G, Griffin MR, Raebel MA, Smith D, Li DK, Pawloski PA, Toh S, Taylor L, Hua W, Horn P, Trinidad JP, Boudreau DM

Prevalence and Medication Treatment of Opioid Use Disorder Among Primary Care Patients with Hepatitis C and HIV.
(2021 Apr)
J Gen Intern Med 36(4): 930-937
Tsui JI, Akosile MA, Lapham GT, Boudreau DM, Johnson EA, Bobb JF, Binswanger IA, Yarborough BJH, Glass JE, Rossom RC, Murphy MT, Cunningham CO, Arnsten JH, Thakral M, Saxon AJ, Merrill JO, Samet JH, Bart GB, Campbell CI, Loree AM, Silva A, Stotts AL, Ahmedani B, Braciszewski JM, Hechter RC, Northrup TF, Horigian VE, Bradley KA

Show complete publication list

In the News

No news articles at this time.